$ALGM

Is Allegro MicroSystems (ALGM) A Bargain As Strong Earnings And Guidance Lift Hopes?

Simply Wall St highlights Allegro MicroSystems (ALGM) after Q1 results of $259.24M revenue and $15.87M net income, plus guidance for higher Q2 net sales. The stock trades at $43.77, up 62.65% YTD. A fair value estimate of $56.55 implies undervaluation, while an SWS DCF model suggests overvaluation versus $24.37.

Original reporting
Published Aug 8, 2026, 12:42 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 9, 2026, 6:58 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Allegro MicroSystems (ALGM) A Bargain As Strong Earnings And Guidance Lift Hopes? — source image
Decision brief

The 30-second read

$ALGMBullishMed
01

Why it matters

For traders, the actionable element is the confirmation of a guidance lift alongside a valuation debate that points to uncertainty about whether the market is over- or under-discounting ALGM’s growth and margin path.

02

Market read

ALGM’s earnings and guidance lift can drive near-term positioning, but the article’s own valuation disagreement and cited China/auto risks suggest elevated dispersion in forward expectations.

03

What to watch

The piece does not provide segment-level revenue breakdowns, margin drivers, or the specific magnitude of the Q2 guidance, limiting conviction on how much the guidance changes forward estimates.

Relevance 6/10Novelty 5/10Timing: post-earnings, ahead of traders’ next positioning around Q2 expectations

Background

The article is a valuation-and-narrative discussion following ALGM’s reported Q1 results and guidance indicating higher Q2 net sales.

Company-level read

Ticker impact

$ALGMBullishMedium confidence
Context

Simply Wall St says Allegro MicroSystems reported Q1 sales of $259.24M, net income of $15.87M, and lifted Q2 net sales guidance.

Expected impact

Likely supports a modest positive bias for ALGM as traders weigh the guidance lift versus the cited swing factors.

Evidence & confidence

The only concrete, company-specific datapoints provided are Q1 results and the existence of higher Q2 net sales guidance; the rest is valuation debate (fair value vs DCF) rather than incremental operational detail.

Market effects

Highlights demand narratives in industrial automation and data center cooling/robotics, which can influence sentiment across analog/power IC and sensor peers.

China pricing competition is flagged as a swing factor, which can affect how traders price China-exposed semiconductor revenue streams.

Reinforces the broader semiconductor theme of earnings-guidance sensitivity to auto and AI/data-center end markets.

Counterpoint

The SWS DCF cited in the article estimates ALGM’s value far below the current price, implying the guidance optimism may already be priced in.

Key entities

  • Allegro MicroSystems

    Reported Q1 sales of $259.24M and net income of $15.87M, and issued guidance indicating higher Q2 net sales.

Related articles

$ALGMHighAI 9/10

ALLEGRO MICROSYSTEMS, INC. (ALGM): Results of Operations and Financial Condition

ALLEGRO MICROSYSTEMS, INC. (ALGM) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 algm-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Allegro MicroSystems Reports First Quarter 2027 Results First Quarter Sales Increased by 27% Year-over-Year to $259 Million Manchester, NH, July 30, 2026 – Allegro MicroSystems, Inc. (“Allegro” or the “Company”) (Nasdaq: ALGM

$LITEMed

Barclays upgrades Lumentum, cuts Allegro, Penguin before chip earnings By Investing.com

Barclays adjusted ratings on U.S. semiconductor stocks ahead of Q2 earnings. It upgraded Lumentum Holdings to Overweight from Equal Weight, citing improving AI networking demand confidence and stronger earnings potential. It downgraded Allegro MicroSystems to Equal Weight and Penguin Solutions to Underweight, citing valuation and weaker near-term fundamentals. Barclays kept Credo Technology Overweight and Astera Labs Equal Weight.

$ALGMMed

TD Cowen Raises PT on Allegro MicroSystems (ALGM)

TD Cowen analyst Joshua Buchalter raised Allegro MicroSystems’ (ALGM) price target from $55 to $70 and kept a Buy rating, after updating the firm’s financial model, according to the report. TD Cowen expects investors to re-rate ALGM’s exposure to automotive and AI data-center growth and projects profitable mid-teen long-term growth.